Online inquiry

IVTScrip™ mRNA-Human ASB7, (Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A))   (CAT#: GTTS-WK22099MR)

This product GTTS-WK22099MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 0 & N1-Methylpseudo-UTP. It ecodes the ASB7 protein. This product can be used in Gonadal endothelial cell-related researches.
Specifications
Product type mRNA
Modified bases N1-Methylpseudo-UTP
5' Cap Cap 0
Species Human
RefSeq NM_024708.4
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 140460
UniProt ID Q9H672
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ASB7, (Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A)) (GTTS-WK22099MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK9475MR IVTScrip™ mRNA-Human ACTRT3, (Cap 0, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA ACTRT3
GTTS-WK27671MR IVTScrip™ mRNA-Human ARFGAP3, (Cap 1, 5-Methoxy-UTP, 30 nt-poly(A)) mRNA ARFGAP3
GTTS-WK25016MR IVTScrip™ mRNA-Human ARHGEF3, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ARHGEF3
GTTS-WK12535MR IVTScrip™ mRNA-Human ADGRD2, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ADGRD2
GTTS-WK12230MR IVTScrip™ mRNA-Human Additional GABA Compounds, (Cap 1, 5-Methyl-CTP, 120 nt-poly(A)) mRNA Additional GABA Compounds
GTTS-WK13171MR IVTScrip™ mRNA-Human ADRM1, (Cap 1, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA ADRM1
GTTS-WK16741MR IVTScrip™ mRNA-Human ANKUB1, (Cap 0, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA ANKUB1
GTTS-WK25912MR IVTScrip™ mRNA-Human ARHGEF19, (Cap 1, 5-Methoxy-UTP, 120 nt-poly(A)) mRNA ARHGEF19
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
webinar

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST

REGISTER NOW